Technical consultant for the development of the national policy on the use of chest X-ray and artificial intelligence for tuberculosis
URGENT CALL FOR APPLICATIONS – Technical Consultant
FHI 360/Philippines (www.fhi360.org) is urgently seeking a Technical consultant provide a short-term work engagement for the USAID-funded “TB Innovations and Health Systems Strengthening” project in the Philippines for the Development of a national policy on the use of chest X-rays and Intelligence for tuberculosis.
According to the 2016 National Tuberculosis Prevalence Survey (NTPS), CXR is a more sensitive screening tool for TB compared to symptoms alone (92% versus 32%, respectively). The World Health Organization (WHO), in its latest publication, has recommended that, as part of routine community-based tuberculosis screening, a sensitive tool such as the CXR followed by an accurate diagnostic test can be used in settings where TB prevalence is even less than 1%.
In addition, it has also been recommended by WHO and DOH-NTP that computer-aided detection (CAD) or artificial intelligence (AI) software can be used as an alternative to the human reader for the initial interpretation of simple digital CXR for early identification screening of clients with possible TB for immediate sputum collection for rapid molecular TB test for bacteriological confirmation. This will further reduce the turnaround time from initial consultation to diagnosis and help save time and costs for consultations, therefore initial losses to follow-up will also be reduced. AI has been used in mobile x-ray departments during active case finding (ACF) in the community and workplace, and has recently been introduced into some healthcare facility workflows as part of intensive case-finding (ICF) or general screening approach among health consultations in public hospitals. Thanks to the availability of these new tools and technologies, the absence or scarcity of radiologists will not hinder the initial detection of tuberculosis.
In collaboration with the Stop TB Partnership and the United States Agency for International Development (USAID), the Philippines is one of six (6) countries under the iNTP (Introducing New Tools Project), to receive a set of new tools to solve problems. and challenges across the continuum of TB care. In coordination with the NTP, these tools will be introduced in six (6) selected sites in the country under programmatic conditions. One of the new tools in the iNTP package is the use of an ultraportable CXR with computer-aided diagnosis (CAD) or artificial intelligence (AI). A special license will be provided by the FDA for the use of ultra-portable CXRs and AIs in the iNTP.
Introducing new tools and technologies and improving TB reporting requires review and revision of government policies and guidelines. There will be a need to develop new guidelines that will support the release of new government policies regarding the use of ultraportable X-rays and computer-aided detection or artificial intelligence software as a screening tool for TB.
Reporting to the Deputy Chief of Party and Private Sector Advisor, the Technical Consultant will perform the following duties:
- Assist in the administrative, financial and procurement direction of FHI.
- Review and collate documents related to clinical practice guidelines on the use of chest X-ray and AI for triage, screening, diagnosis and monitoring of tuberculosis (TB policies on recording and local and international licensing)
- Facilitate dialogues and consultations with the DOH-Food and Drug Administration (FDA), Health Facilities and Services Regulatory Bureau (HFSRB), World Health Organization (WHO), and other relevant stakeholders ( i.e. end users, x-ray providers, radiologists, other TB technical partners) as part of collecting information for the development of guidelines and recommendations.
- Development of guidelines that will support the issuance of policies that will include the following: (in collaboration with consultant on development of clinical practice guidelines: licensing and registration of portable/ultraportable X-rays and IA CXR, FDA clearance for X-ray facilities to include submission of TB screening activities using CXR (as part of the hospital facility report to be submitted (Form 3) which will contribute to the screening objectives of PhilSTEP1
- Presentation of draft guidelines to stakeholders.
- Finalization of guidelines incorporating all stakeholder input.
Education/work experience/skills required
- Degree in medicine or paramedical courses, public health, public administration or other related fields
- Preferably a master’s degree in public health and/or public administration
- 3-5 years of experience in public health policy development
- Demonstrable in-depth experience in drafting local health policies
- Ability to moderate a group of professionals and experts and is familiar with the clinical programmatic management of TB and the use of CXR and CAD
- Can bring together appropriate local and international policies related to tuberculosis, coronary artery disease and other relevant respiratory diseases
Place of work/Assignment
Target commitment period
As soon as possible – August 2022 (18 days LOE)
How to register
Send a letter of intent and an updated CV/curriculum vitae in a single pdf file to [email protected] on or June 15, 2022. Please indicate the position you are applying for in the subject line following this title format below. Shortlisted candidates will be notified of the next selection process.
FHI360-Position Requested -Candidate Last Name (Example: FHI360-TBIHSS-**Technical Consultant-Dev’t of National Policy-**Cruz).
FHI 360 promotes the strength and health of its workforce through a set of competitive benefits, professional development; and policies and programs that support a healthy work-life balance. Join our global workforce to make a positive difference for others – and for yourself.
FHI360 is an equal employment and affirmative action employer whereby we do not engage in practices that discriminate against any person employed or seeking employment because of their race, color, religion, sex, sexual orientation, gender identity, national or ethnic origin, age, marital status, disability, veteran status, genetic information or any other status or characteristic protected by applicable law.